D. Machover

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 433 citations · Full text

Oncology, Medicine, Colorectal Cancer +5

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

D. Machover, Emma Goldschmidt, P. Chollet et al. · Journal of Clinical Oncology · 1986 · 397 citations

Gastric Adenocarcinomas, Expanded Trial, Surgical Oncology +15

Hepatic Resection After Rescue Cetuximab Treatment for Colorectal Liver Metastases Previously Refractory to Conventional Systemic Therapy

René Adam, Thomas A. Aloia, Françis Lévi et al. · Journal of Clinical Oncology · 2007 · 205 citations · Full text

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Stéphane de Botton, Miguel Á. Sanz, Sylvie Chevret et al. · Leukemia · 2005 · 159 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +11